A
Arrowhead Research
Pasadena, United States
Founded 2003 NASDAQ: ARWR
About
Biopharmaceutical company developing targeted RNAi therapeutics using proprietary TRiM platform
Company Details
- Type
- commercial
- Employees
- 200-500
- Funding
- $500M+
Key Products
- ARO-AAT
- ARO-APOC3
- ARO-HBV